企業プロフィール

Oragenics 株価・ニュース・カタリスト

ティッカー:
OGEN
取引所:
AMEX
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

0.54 USD (+0.39%)

終値

最終更新: 2026年8月17日

2.75M USD

時価総額

株価変動の要因

As of Aug 17, 2026, OGEN closed up 0.39% at $0.5350. No new same-company headline was identified in the current news window.

企業概要

事業概要

Oragenics is a biotechnology company focused on infectious disease and central nervous system programs. Its story has long been about using small-cap biotech tools to pursue high-unmet-need therapeutic areas.

所在地とセクター分類

Oragenics is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.

ビジネスモデルの特徴

The company depends on early-stage scientific validation, capital discipline, and the ability to focus its pipeline. Investors watch platform shifts, early data, and financing runway.

バイオ業界での位置付け

Oragenics occupies a speculative small-cap biotech niche. The stock is driven by whether the company can sharpen its thesis enough to sustain investor confidence.

今後のカタリスト

  • Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone. The market is focused on residual value.

最近のニュース

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

類似銘柄

事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。